Diseases

Embed Size (px)

DESCRIPTION

diseses of cancer

Text of Diseases

CHRNA1|Myasthenic syndrome|congenital|fast-channelCHRNA1|Myasthenic syndrome|congenital|slow-channelCHRNE|Myasthenic syndrome|slow-channel congenital|autosomal recessiveCHRNE|Myasthenic syndrome|slow-channel congenitalCHRNE|Myasthenic syndrome|fast-channel congenitalCHRNE|Myasthenic syndrome|congenital|fast-channelCHRNE|Myasthenic syndrome|congenital|associated with acetylcholine receptor deficiencyCHRNG|Escobar syndromeCHRNG|Multiple pterygium syndrome|lethal typeACHE|YT blood group polymorphismASCL1|Haddad syndromeASCL1|Central hypoventilation syndrome|congenitalACTC1|Cardiomyopathy|familial hypertrophicACTC1|Cardiomyopathy|dilated|1RACTG1|Deafness|autosomal dominant 20FLNC|Filaminopathy|autosomal dominantACVR1|Fibrodysplasia ossificans progressivaAPRT|APRT deficiency due to type I alleleAPRT|APRT deficiency|Japanese typeAPRT|APRT deficiencyACTA1|Nemaline myopathy 3ACTA1|Myopathy|congenital|with fiber-type Disproportion 1ACTA1|Myopathy|actin|congenital|with coresACTA1|Myopathy|actin|congenital|with excess of thin myofilamentsACTB|Dystonia|juvenile-onsetADD1|Hypertension|salt-sensitive essential|susceptibility toADA|Severe combined immunodeficiency|autosomal recessive|T cell-negative|B cell-negative|NK cell-negative|due to adenosine deaminase deficiency|delayed onsetADA|Adenosine deaminase deficiency|partialADA|Severe combined immunodeficiency|autosomal recessive|T cell-negative|B cell-negative|NK cell-negative|due to adenosine deaminase deficiencyADA|Adenosine deaminase 2 allozymeADA|Severe combined immunodeficiency|autosomal recessive|T cell-negative|B cell-negative|NK cell-negative|due to adenosine deaminase deficiency|late-onsetADA|Severe combined immunodeficiency|autosomal recessive|T cell-negative|B cell-negative|NK cell-negative|due to adenosine deaminase deficiency|late onsetADA|Severe combined immunodeficiency|autosomal recessive|T cell-negative|B cell-negative|NK cell-negative|due to adenosine deaminase deficiency|B cell-negative|NK cell-negative|due to ada deficiencyAMPD1|AMPD deficiencyAMPD3|AMP deaminase deficiency of erythrocyteAK1|Adenylate kinase deficiency|hemolytic anemia due toADSL|Adenylosuccinase deficiencySLC25A4|Progressive external ophthalmoplegia with mitochondrial DNA deletions|autosomal dominant|2ALB|AnalbuminemiaALB|Albumin SondriaALB|Albumin Rugby ParkALB|Albumin Malmo 47ALB|Albumin Malmo 10ALB|Albumin Malmo 95ALB|Albumin Malmo 5ALB|Albumin DublinALB|Albumin CasebrookALB|Albumin Iowa City 1ALB|Albumin GhentALB|Albumin Vibo ValentiaALB|Albumin TorinoALB|Albumin Castel di SangroALB|Proalbumin MalmoALB|Albumin RedhillALB|Albumin Fukuoka 1ALB|Albumin Osaka 1ALB|Albumin NagoyaALB|Albumin BremenALB|Albumin Honolulu 2ALB|Albumin Porto Alegre 1ALB|Albumin Hiroshima 1ALB|Albumin Nagasaki 1ALB|Albumin Hiroshima 2ALB|Albumin TochigiALB|Albumin Osaka 2ALB|Albumin Fukuoka 2ALB|Proalbumin JaffnaALB|Albumin VanvesALB|Albumin RomaALB|Albumin New GuineaALB|Albumin VeneziaALB|Albumin GE/CTALB|Analbuminemia|American Indian typeALB|Albumin Honolulu 1ALB|Albumin Nagasaki 3ALB|Albumin Yanomama 2ALB|Albumin Nagasaki 2ALB|Albumin MakuALB|Albumin ParklandsALB|Albumin LambadiALB|Albumin Mexico 2ALB|Albumin MersinALB|Albumin AsolaALB|Albumin OrtonovoALB|Albumin Tradate 2ALB|Albumin BazzanoALB|Albumin CasertaALB|Albumin LarinoALB|Dysalbuminemic hyperthyroxinemiaALB|Analbuminemia RomaALB|Albumin Hawkes BayALB|Albumin HerbornADH1B|Alcohol dehydrogenase|beta subunit|IndianapolisADH1B|Alcohol dehydrogenase|beta subunit|'typical'/'atypical'ADH1C|Parkinson disease|susceptibility toADH1C|Alcohol dehydrogenase|gamma-2 typeADH1C|Alcohol dehydrogenase|gamma-1 typeALDOA|Aldolase deficiency of red cellsALDOA|Myopathy and hemolytic anemiaA2M|Alpha-2-macroglobulin polymorphismA2M|Alzheimer disease|susceptibility toAFP|Alpha-fetoprotein deficiencyAFP|Alpha-fetoprotein|hereditary persistence ofZFHX3|Prostate cancerNAGA|Schindler disease|type INAGA|Kanzaki diseaseNAGA|Schindler disease|type IIIADRA2C|Congestive heart failure|susceptibility toPSEN1|Dementia|frontotemporalPSEN1|Alzheimer disease|familial|3|with spastic paraparesis and apraxiaPSEN1|Alzheimer disease|familial|3|with unusual plaquesPSEN1|Pick disease of brainPSEN1|Alzheimer disease|familial|3|with spastic paraparesis and unusual plaquesPSEN1|Cardiomyopathy|dilated|1UPSEN1|Alzheimer disease|familial|3PSEN1|Alzheimer disease|familial|with spastic paraparesis and unusual plaquesSLC3A1|CystinuriaACY1|Aminoacylase 1 deficiencySAA1|Serum amyloid A variantAPP|Amyloidosis|cerebroarterial|hereditary|Italian typeAPP|Amyloidosis|cerebroarterial|hereditary|Iowa typeAPP|APP polymorphismAPP|Alzheimer disease|early-onset|with cerebral amyloid angiopathyAPP|Alzheimer disease|familial|1APP|Amyloidosis|with cerebral hemorrhage|hereditary|Dutch typeANG|Amyotrophic lateral sclerosis|susceptibility toAGT|Renal tubular dysgenesisAGT|Hypertension|essential|susceptibility toAGTR1|Stature as a quantitative traitAGTR1|Renal tubular dysgenesisAGTR1|Hypertension|essential|susceptibility toACE|Angiotensin I-converting enzyme|benign serum increaseACE|Angiotensin I-converting enzyme insertion/deletion polymorphismACE|Renal tubular dysgenesisANK2|Long GT syndrome 4ANK2|Sick sinus syndrome with bradycardiaCD19|Antibody deficiency due to defect in CD19CD44|Indian blood group system polymorphismCD59|CD59 deficiencySERPINA3|Antichymotrypsin Isehara 2SERPINA3|Antichymotrypsin Isehara 1SERPINA3|Antichymotrypsin signal peptide polymorphismSERPINA3|Antichymotrypsin Bochum 1SERPINA3|Antichymotrypsin Bonn 1SERPINC1|Antithrombin deficiencySERPINC1|Antithrombin 3 deficiencySERPINC1|At-III StockholmSERPINC1|At-III OsloSERPINC1|At-III deficiencySERPINC1|At-III BudapestSERPINC1|At-III Budapest 3SERPINC1|Thrombophilia due to antithrombin III deficiencySERPINC1|At-III Cambridge IISERPINC1|At-III Rouen ivSERPINC1|At-III BaselSERPINC1|At-III Rouen IIISERPINC1|At-III HamiltonSERPINC1|At-III AvranchesSERPINC1|At-III UtahSERPINC1|At-III Rouen IIISERPINC1|At-III BarcelonaSERPINC1|At-III Barcelona 2SERPINC1|At-III DublinSERPINC1|At-III DenverSERPINC1|At-III Rouen ISERPINC1|At-III Northwick ParkSERPINC1|At-III GlasgowSERPINC1|At-III ClichySERPINC1|At-III FontainbleauSERPINC1|At-III PescaraSERPINC1|At-III TrentoSERPINC1|At-III RomaSERPINC1|At-III ToyamaSERPINC1|At-III CharlevilleSERPINC1|At-III Padua 2SERPINC1|At-III ParisSERPINC1|At-III Rouen VISERPINC1|At-III NagasakiALDH7A1|Epilepsy|pyridoxine-dependentIFNGR1|Atypical mycobacterial infection|autosomal dominantIFNGR1|Bcg infection|generalized familial semibenignIFNGR1|Atypical mycobacterial infection|disseminatedIFNGR1|Atypical mycobacterial infection|disseminated familialIFNGR1|Helicobacter pylori infection|susceptibility toIFNGR1|Atypical mycobacterial infection|familial disseminatedIFNGR1|BCG infection|generalized familialIFNGR1|BCG infection|tuberculoid|antibiotic-responsiveAPOA2|Hypercholesterolemia|familial|modification ofAPOA2|Apolipoprotein A-II deficiency|familial|due to APOA-II (Hiroshima)APOA4|Apolipoprotein A-IV rare variant|APOA4*5APOA4|Apolipoprotein A-IV rare variant|APOA4*0APOA4|Apolipoprotein A-IV rare variant|APOA4*3APOA4|Apolipoprotein A-IV polymorphism|APOA4*1/APOA4*2APOC3|Apolipoprotein c-III deficiencyAPOC3|Apolipoprotein c-III|nonglycosylatedAPOB|Hypobetalipoproteinemia|familial|associated with APOB32APOB|APOB polymorphism in signal peptideAPOB|Hypobetalipoproteinemia|familial|associated with APOB87APOB|Hypobetalipoproteinemia|familial|associated with APOB31APOB|Hypobetalipoproteinemia|familial|associated with APOB40APOB|Hypobetalipoproteinemia|familial|associated with APOB90 or APOB89APOB|Hypobetalipoproteinemia|familial|associated with APOB46APOB|Hypobetalipoproteinemia|familial|associated with APOB39APOB|Hypobetalipoproteinemia|familialAPOB|Hypercholesterolemia due to ligand-defective apolipoprotein B100APOB|Hypobetalipoproteinemia|normotriglyceridemicAPOB|Hypercholesterolemia due to ligand-defective apolipoprotein BAPOE|APOE3(-)-FreiburgAPOE|Myocardial infarction|susceptibility toAPOE|Sea-blue histiocyte diseaseAPOE|Hyperlipoproteinemia|type III|due to APOE1-HarrisburgAPOE|Hyperlipoproteinemia|type III|associated with APOE deficiency|autosomal recessiveAPOE|Hyperlipoproteinemia|type III|associated with APOE2-FukuokaAPOE|Hyperlipoproteinemia|type III|due to APOE4-PhiladelphiaAPOE|Hypercholesterolemia and hypertriglyceridemia|type IIIAPOE|Hyperlipoproteinemia|type IIIAPOE|Dysbetalipoproteinemia due to APOE2APOE|APOE2-DunedinAPOE|Hyperlipoproteinemia|type III|associated with APOE7APOE|Hyperlipoproteinemia and atherosclerosis associated with APOE5APOE|Hyperlipoproteinemia|type III|associated with APOE deficiencyAPOE|Hyperlipoproteinemia|type III|due to APOE2-ChristchurchAPOE|APOE4 variantAPOE|Hyperlipoproteinemia|type III|associated with APOE LeidenAPOE|APOE2 isoformsAPOE|Hyperlipoproteinemia|type III|associated with APOE2APOE|Apolipoproteinemia E1APOE|APOE3 variantAPOE|Hyperlipoproteinemia|type III|autosomal dominantAPOE|Alzheimer disease 2APOE|APOE3 isoformAPOE|APOE2 variantAPOE|Hyperlipoproteinemia|type III|associated with APOE4APOE|APOE4(+)AQP1|Aquaporin 1 deficiencyAQP1|Colton blood group polymorphismAQP2|Diabetes insipidus|nephrogenic|autosomal recessiveAQP2|Diabetes insipidus|nephrogenic|autosomal dominantDDC|Aromatic l-amino acid decarboxylase deficiencyNAT1|NAT1*10 alleleNAT1|NAT1*17 alleleATP2A1|Brody myopathyATP2B2|Deafness|autosomal recessive 12|modifier ofATP2A2|Darier diseaseATP2A2|Darier disease|acral hemorrhagic typeATP2A2|Darier disease|segmentalATP2A2|Acrokeratosis verruciformisNPR2|Acromesomelic dysplasia|maroteaux typeSLC4A1|Spherocytosis|hereditary|due to band 3 TuscaloosaSLC4A1|Waldner blood group antigenSLC4A1|Renal tubular acidosis|autosomal dominantSLC4A1|Froese blood group antigenSLC4A1|Swann blood group antigenSLC4A1|Spherocytosis|hereditary|due to band 3 Cape TownSLC4A1|Spherocytosis|hereditary|due to band 3 Prague IIISLC4A1|Spherocytosis|hereditary|due to band 3 Prague iiSLC4A1|Ovalocytosis|southeast asianSLC4A1|